Research groups
Publications and research
Scientific publications
Solhaug, Vigdis; Haslemo, Tore; Kringen, Marianne Kristiansen; Molden, Espen; Dietrichs, Erik Sveberg
(2022).
Genotyping av pasienter behandlet med selektive serotoninreopptakshemmere.
9 p.
Tidsskrift for Den norske legeforening.
Vol. 142.
https://doi.org/10.4045/tidsskr.22.0017
Hole, Kristine; Arnestad, Marianne; Molden, Espen; Haslemo, Tore
(2021).
Dose-Dependent Inhibition of CYP2D6 by Bupropion in Patients with Depression.
4 p.
Journal of Clinical Psychopharmacology.
Vol. 41.
https://doi.org/10.1097/JCP.0000000000001387
Tveito, Marit; Høiseth, Gudrun; Haslemo, Tore; Molden, Espen; Smith, Robert Løvsletten
(2021).
Impact of age and gender on paliperidone exposure in patients after administration of long-acting injectable formulations—an observational study using blood samples from 1223 patients.
European Journal of Clinical Pharmacology.
Vol. 77.
https://doi.org/10.1007/s00228-021-03114-z
Bråten, Line Skute; Haslemo, Tore; Jukić, Marin M.; Ivanov, Maxim; Ingelman-Sundberg, Magnus; Molden, Espen; Kringen, Marianne K.
(2021).
A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of Escitalopram.
Clinical Pharmacology and Therapeutics.
Vol. 110.
https://doi.org/10.1002/cpt.2233
Kringen, Marianne K.; Bråten, Line Skute; Haslemo, Tore; Molden, Espen
(2020).
The Influence of Combined CYP2D6 and CYP2C19 Genotypes on Venlafaxine and O -Desmethylvenlafaxine Concentrations in a Large Patient Cohort.
7 p.
Journal of Clinical Psychopharmacology.
Vol. 40.
https://doi.org/10.1097/JCP.0000000000001174
Bråten, Line Skute; Haslemo, Tore; Jukic, Marin M.; Ingelman-Sundberg, Magnus; Molden, Espen; Kringen, Marianne K.
(2019).
Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients.
Neuropsychopharmacology.
Vol. 45.
https://doi.org/10.1038/s41386-019-0554-x
Gjestad, Caroline; Hole, Kristine; Haslemo, Tore; Diczfalusy, Ulf; Molden, Espen
(2019).
Effect of Grapefruit Juice Intake on Serum Level of the Endogenous CYP3A4 Metabolite 4β-Hydroxycholesterol—an Interaction Study in Healthy Volunteers.
7 p.
AAPS Journal.
Vol. 21.
https://doi.org/10.1208/s12248-019-0330-1
Jukic, Marin M.; Smith, Robert Løvsletten; Haslemo, Tore; Molden, Espen; Ingelman-Sundberg, Magnus
(2019).
Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study.
The Lancet Psychiatry.
Vol. 6.
https://doi.org/10.1016/S2215-0366(19)30088-4
Smith, Robert Løvsletten; Kyllesø, Lennart; Haslemo, Tore; Andreassen, Ole Andreas; Molden, Espen
(2019).
Reduction in N-desmethylclozapine level is determined by daily dose but not serum concentration of valproic acid-indications of a presystemic interaction mechanism.
Therapeutic Drug Monitoring.
Vol. 41.
https://doi.org/10.1097/FTD.0000000000000619
Jukic, Marin M.; Haslemo, Tore; Molden, Espen; Ingelman-Sundberg, Magnus
(2018).
Impact of CYP2C19 Genotype on Escitalopram Exposure
and Therapeutic Failure: A Retrospective Study Based on
2,087 Patients.
American Journal of Psychiatry.
Vol. 175.
https://doi.org/10.1176/appi.ajp.2017.17050550